Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
This report aims to provide a comprehensive presentation of the global market for Natural Killer Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer Cell Therapy. This report contains market size and forecasts of Natural Killer Cell Therapy in global, including the following market information:
Global Natural Killer Cell Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Natural Killer Cell Therapy market was valued at US$ 263.2 million in 2022 and is projected to reach US$ 1131.3 million by 2029, at a CAGR of 23.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.
We surveyed the Natural Killer Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Natural Killer Cell Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Natural Killer Cell Therapy Market Segment Percentages, by Type, 2022 (%)
NK Cell Therapies
NK Cell Directed Antibodies
Global Natural Killer Cell Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Natural Killer Cell Therapy Market Segment Percentages, by Application, 2022 (%)
Cancer
Gastrointestinal Diseases
Others
Global Natural Killer Cell Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Natural Killer Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Natural Killer Cell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Natural Killer Cell Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
Outline of Major Chapters:
Chapter 1: Introduces the definition of Natural Killer Cell Therapy, market overview.
Chapter 2: Global Natural Killer Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of Natural Killer Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Natural Killer Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Natural Killer Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Natural Killer Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Natural Killer Cell Therapy Overall Market Size
2.1 Global Natural Killer Cell Therapy Market Size: 2022 VS 2029
2.2 Global Natural Killer Cell Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Natural Killer Cell Therapy Players in Global Market
3.2 Top Global Natural Killer Cell Therapy Companies Ranked by Revenue
3.3 Global Natural Killer Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Natural Killer Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Natural Killer Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Natural Killer Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Natural Killer Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Natural Killer Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Natural Killer Cell Therapy Market Size Markets, 2022 & 2029
4.1.2 NK Cell Therapies
4.1.3 NK Cell Directed Antibodies
4.2 By Type - Global Natural Killer Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global Natural Killer Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global Natural Killer Cell Therapy Revenue, 2024-2029
4.2.3 By Type - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Natural Killer Cell Therapy Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Gastrointestinal Diseases
5.1.4 Others
5.2 By Application - Global Natural Killer Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global Natural Killer Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global Natural Killer Cell Therapy Revenue, 2024-2029
5.2.3 By Application - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Natural Killer Cell Therapy Market Size, 2022 & 2029
6.2 By Region - Global Natural Killer Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Natural Killer Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global Natural Killer Cell Therapy Revenue, 2024-2029
6.2.3 By Region - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Natural Killer Cell Therapy Revenue, 2018-2029
6.3.2 US Natural Killer Cell Therapy Market Size, 2018-2029
6.3.3 Canada Natural Killer Cell Therapy Market Size, 2018-2029
6.3.4 Mexico Natural Killer Cell Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Natural Killer Cell Therapy Revenue, 2018-2029
6.4.2 Germany Natural Killer Cell Therapy Market Size, 2018-2029
6.4.3 France Natural Killer Cell Therapy Market Size, 2018-2029
6.4.4 U.K. Natural Killer Cell Therapy Market Size, 2018-2029
6.4.5 Italy Natural Killer Cell Therapy Market Size, 2018-2029
6.4.6 Russia Natural Killer Cell Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Natural Killer Cell Therapy Market Size, 2018-2029
6.4.8 Benelux Natural Killer Cell Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Natural Killer Cell Therapy Revenue, 2018-2029
6.5.2 China Natural Killer Cell Therapy Market Size, 2018-2029
6.5.3 Japan Natural Killer Cell Therapy Market Size, 2018-2029
6.5.4 South Korea Natural Killer Cell Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Natural Killer Cell Therapy Market Size, 2018-2029
6.5.6 India Natural Killer Cell Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Natural Killer Cell Therapy Revenue, 2018-2029
6.6.2 Brazil Natural Killer Cell Therapy Market Size, 2018-2029
6.6.3 Argentina Natural Killer Cell Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Natural Killer Cell Therapy Revenue, 2018-2029
6.7.2 Turkey Natural Killer Cell Therapy Market Size, 2018-2029
6.7.3 Israel Natural Killer Cell Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Natural Killer Cell Therapy Market Size, 2018-2029
6.7.5 UAE Natural Killer Cell Therapy Market Size, 2018-2029
7 Natural Killer Cell Therapy Companies Profiles
7.1 Nektar Therapeutics
7.1.1 Nektar Therapeutics Company Summary
7.1.2 Nektar Therapeutics Business Overview
7.1.3 Nektar Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.1.4 Nektar Therapeutics Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Nektar Therapeutics Key News & Latest Developments
7.2 Innate Pharma SA
7.2.1 Innate Pharma SA Company Summary
7.2.2 Innate Pharma SA Business Overview
7.2.3 Innate Pharma SA Natural Killer Cell Therapy Major Product Offerings
7.2.4 Innate Pharma SA Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Innate Pharma SA Key News & Latest Developments
7.3 Affimed
7.3.1 Affimed Company Summary
7.3.2 Affimed Business Overview
7.3.3 Affimed Natural Killer Cell Therapy Major Product Offerings
7.3.4 Affimed Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Affimed Key News & Latest Developments
7.4 Chipscreen Biosciences
7.4.1 Chipscreen Biosciences Company Summary
7.4.2 Chipscreen Biosciences Business Overview
7.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Major Product Offerings
7.4.4 Chipscreen Biosciences Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 Chipscreen Biosciences Key News & Latest Developments
7.5 Glycostem Therapeutics
7.5.1 Glycostem Therapeutics Company Summary
7.5.2 Glycostem Therapeutics Business Overview
7.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.5.4 Glycostem Therapeutics Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 Glycostem Therapeutics Key News & Latest Developments
7.6 Fate Therapeutics
7.6.1 Fate Therapeutics Company Summary
7.6.2 Fate Therapeutics Business Overview
7.6.3 Fate Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.6.4 Fate Therapeutics Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 Fate Therapeutics Key News & Latest Developments
7.7 Dragonfly Therapeutics
7.7.1 Dragonfly Therapeutics Company Summary
7.7.2 Dragonfly Therapeutics Business Overview
7.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.7.4 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 Dragonfly Therapeutics Key News & Latest Developments
7.8 Kiadis Pharma
7.8.1 Kiadis Pharma Company Summary
7.8.2 Kiadis Pharma Business Overview
7.8.3 Kiadis Pharma Natural Killer Cell Therapy Major Product Offerings
7.8.4 Kiadis Pharma Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Kiadis Pharma Key News & Latest Developments
7.9 Nkarta Therapeutics
7.9.1 Nkarta Therapeutics Company Summary
7.9.2 Nkarta Therapeutics Business Overview
7.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.9.4 Nkarta Therapeutics Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 Nkarta Therapeutics Key News & Latest Developments
7.10 NantKwest
7.10.1 NantKwest Company Summary
7.10.2 NantKwest Business Overview
7.10.3 NantKwest Natural Killer Cell Therapy Major Product Offerings
7.10.4 NantKwest Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 NantKwest Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Natural Killer Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Natural Killer Cell Therapy Market Drivers in Global Market
Table 3. Natural Killer Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Natural Killer Cell Therapy in Global Market
Table 5. Top Natural Killer Cell Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Natural Killer Cell Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Natural Killer Cell Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Natural Killer Cell Therapy Product Type
Table 9. List of Global Tier 1 Natural Killer Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Natural Killer Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Natural Killer Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Natural Killer Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Natural Killer Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Natural Killer Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Natural Killer Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Natural Killer Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Natural Killer Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Natural Killer Cell Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Natural Killer Cell Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Natural Killer Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Natural Killer Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Natural Killer Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Natural Killer Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Natural Killer Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Nektar Therapeutics Company Summary
Table 31. Nektar Therapeutics Natural Killer Cell Therapy Product Offerings
Table 32. Nektar Therapeutics Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Nektar Therapeutics Key News & Latest Developments
Table 34. Innate Pharma SA Company Summary
Table 35. Innate Pharma SA Natural Killer Cell Therapy Product Offerings
Table 36. Innate Pharma SA Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Innate Pharma SA Key News & Latest Developments
Table 38. Affimed Company Summary
Table 39. Affimed Natural Killer Cell Therapy Product Offerings
Table 40. Affimed Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Affimed Key News & Latest Developments
Table 42. Chipscreen Biosciences Company Summary
Table 43. Chipscreen Biosciences Natural Killer Cell Therapy Product Offerings
Table 44. Chipscreen Biosciences Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Chipscreen Biosciences Key News & Latest Developments
Table 46. Glycostem Therapeutics Company Summary
Table 47. Glycostem Therapeutics Natural Killer Cell Therapy Product Offerings
Table 48. Glycostem Therapeutics Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Glycostem Therapeutics Key News & Latest Developments
Table 50. Fate Therapeutics Company Summary
Table 51. Fate Therapeutics Natural Killer Cell Therapy Product Offerings
Table 52. Fate Therapeutics Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Fate Therapeutics Key News & Latest Developments
Table 54. Dragonfly Therapeutics Company Summary
Table 55. Dragonfly Therapeutics Natural Killer Cell Therapy Product Offerings
Table 56. Dragonfly Therapeutics Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Dragonfly Therapeutics Key News & Latest Developments
Table 58. Kiadis Pharma Company Summary
Table 59. Kiadis Pharma Natural Killer Cell Therapy Product Offerings
Table 60. Kiadis Pharma Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Kiadis Pharma Key News & Latest Developments
Table 62. Nkarta Therapeutics Company Summary
Table 63. Nkarta Therapeutics Natural Killer Cell Therapy Product Offerings
Table 64. Nkarta Therapeutics Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Nkarta Therapeutics Key News & Latest Developments
Table 66. NantKwest Company Summary
Table 67. NantKwest Natural Killer Cell Therapy Product Offerings
Table 68. NantKwest Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. NantKwest Key News & Latest Developments
List of Figures
Figure 1. Natural Killer Cell Therapy Segment by Type in 2022
Figure 2. Natural Killer Cell Therapy Segment by Application in 2022
Figure 3. Global Natural Killer Cell Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Natural Killer Cell Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Natural Killer Cell Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Natural Killer Cell Therapy Revenue in 2022
Figure 8. By Type - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Natural Killer Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Natural Killer Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 16. US Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 28. China Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Nektar Therapeutics Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Innate Pharma SA Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Affimed Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Chipscreen Biosciences Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Glycostem Therapeutics Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Fate Therapeutics Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Dragonfly Therapeutics Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Kiadis Pharma Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Nkarta Therapeutics Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. NantKwest Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
